Biological Safety Testing Products and Services Market to grow with a CAGR of 9.10% through 2029

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Global Biological Safety Testing Products and Services Market in the forecast period, 2025-2029. 

According to TechSci Research report, “Biological Safety Testing Products and Services Market - Global Industry Size, Share, Trends, Competition, Forecast & Opportunities, 2029F”, Global Biological Safety Testing Products and Services Market was valued at USD 3.98 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 9.10% through 2029. Stringent regulatory standards in the biopharmaceutical and biotechnology sectors, particularly concerning the safety and quality of biological products, are driving increased demand for biological safety testing products and services. Regulatory bodies like the FDA and EMA enforce rigorous testing protocols to ensure compliance with safety standards, necessitating specialized testing solutions.

The growth in research and development activities within the biopharmaceutical field, driven by heightened investments in drug discovery and development, is further fueling the need for biological safety testing products and services. Biopharmaceutical companies are continuously innovating and developing new biologics, biosimilars, and cell and gene therapies, which require comprehensive safety testing throughout their development lifecycle. Additionally, the rise in infectious diseases and the emergence of new pathogens are increasing the demand for biological safety testing, particularly in vaccine development and manufacturing. As global healthcare faces infectious disease outbreaks, there is a greater focus on ensuring vaccine safety and efficacy through stringent testing procedures.

Technological advancements in biotechnology and life sciences, such as genomics, proteomics, and cell culture technologies, are also driving the demand for advanced biological safety testing solutions. These innovations facilitate the development of complex biopharmaceutical products, necessitating sophisticated testing methodologies for accurate safety assessments. Moreover, the increasing adoption of biologics and biosimilars for treating various diseases is boosting the demand for biological safety testing products and services. These products require rigorous safety testing to ensure quality, purity, and efficacy, thereby contributing to market growth. The expansion of the pharmaceutical and biotechnology industries, particularly in emerging markets, further amplifies the demand for biological safety testing solutions to meet regulatory requirements and ensure product safety and quality. Additionally, the growing focus on personalized medicine and targeted therapies is driving the need for specialized biological safety testing tailored to specific patient populations, supporting the advancement of individualized treatment approaches.

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on " Global Biological Safety Testing Products and Services Market”

Global Biological Safety Testing Products and Services Market is segmented based on Product, Application, Test Type, Regional Distribution and Company.

Based on Application, Vaccines & Therapeutics have emerged as the dominating segment in the Global Biological Safety Testing Products and Services Market in 2023. Global health crises, such as pandemics or emerging infectious diseases, can significantly increase the demand for vaccines & therapeutics. For instance, the COVID-19 pandemic created a substantial need for vaccine development and testing, likely impacting the market share of this segment. Vaccines & therapeutic products undergo rigorous regulatory scrutiny and testing to ensure their safety and efficacy, necessitating a range of biological safety testing services to meet these standards. Continuous research and development efforts in the pharmaceutical and biotechnology industries further drive the demand for biological safety testing. New vaccines & therapeutic agents require extensive testing throughout their development phases. Additionally, government-backed public health initiatives aimed at combating infectious diseases, such as immunization programs, often lead to the mass production of vaccines. Ensuring the safety of these vaccines is critical, further underscoring the importance of comprehensive biological safety testing.

Based on Region, Asia Pacific have emerged as the fastest growing region in Global Biological Safety Testing Products and Services Market during the forecast period. The regulatory landscape in the Asia Pacific region, particularly in emerging economies, is evolving to emphasize stringent compliance standards for biological safety testing. Regulatory bodies are aligning with global standards, necessitating robust safety testing protocols for biopharmaceutical and biotechnology products. This regulatory framework is driving demand for biological safety testing products and services. The biopharmaceutical industry in the Asia Pacific region is experiencing rapid growth due to increased investments in healthcare infrastructure, rising R&D expenditures, and growing demand for innovative therapeutics. Biopharmaceutical companies are focusing on developing novel biologics, biosimilars, and cell and gene therapies, underscoring the need for comprehensive biological safety testing throughout the product development lifecycle.

Some of the major companies operating in the Global Biological Safety Testing Products and Services Market include:

• Charles River Laboratories International, Inc. 
• BSL Bioservice Scientific Laboratories Munich GmbH
• Merck KGaA 
• Samsung Biologics
• Sartorius AG
• Eurofins Scientific (Ireland) Limited
• SGS Société Générale de Surveillance SA 
• Thermo Fisher Scientific Inc.
• BIOMÉRIEUX SA
• Lonza Group Ltd.

Download Free Sample Report

Customers can also request 10% free customization on this report

“Certain regions, particularly in North America, are anticipated to drive significant demand for Biological Safety Testing Products and Services. The competitive landscape's growth and the presence of well-established companies dedicated to enhancing overall well-being are expected to contribute to substantial growth in the Global Biological Safety Testing Products and Services Market during the forecast period", said Mr. Karan Chechi, Research Director of TechSci Research, a research-based Global management consulting firm.

"Biological Safety Testing Products and Services Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Reagents & Kits, Services, Instruments), By Application (Vaccines & Therapeutics, Gene Therapy, Monoclonal Antibodies, Recombinant Protein, Blood & Blood-based Products, Tissue & Tissue-based Products, Stem Cells), By Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication & Characterization Tests, Bioburden Tests, Adventitious Agent Detection Tests, Residual Host Contamination Detection Tests, Others), By Region and Competition, 2019-2029F" has evaluated the future growth potential of Global Biological Safety Testing Products and Services Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Biological Safety Testing Products and Services Market.

Contact

Techsci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +13322586602

Email: [email protected]

Website: www.techsciresearch.com